Now, Erbitux has been approved after all, and ImClone's stock has rebounded.

现在，西妥昔单抗毕竟还是获批了，英克隆的股价也已反弹。

youdao

The 222 patients treated with Erbitux and chemotherapy survived for an average of 40 weeks.

接受艾比特思和化学疗法联合治疗的222名患者平均幸存了40周。

youdao

Erbitux, for example, binds to a cell-surface protein called epidermal growth-factor receptor (EGFR).

例如，艾比特思和名为表皮生长因子受体(EGFR)的细胞表面蛋白的结合。

youdao

Several studies showed that all responses to Erbitux are in this group of patients.

FORBES: ImClone Gets Targeted

"I think Erbitux is more of a treatment than we've given it credit for, " Venook says.

FORBES: ImClone's Next Hurdles: Cost And Competition

But now Erbitux appears to have lost the advantage of being first to market.

FORBES: Magazine Article